Turkiye Klinikleri Journal of Veterinary Sciences

.: REVIEW
Kedilerin İntersitisyel Sistitisi - Pandora Sendromu: Geleneksel Derleme
Feline Intersitiel Cystitis - Pandora Syndrome: Traditional Review
Erdem GÜLERSOYa, Mehmet MADENb
aHarran Üniversitesi Veteriner Fakültesi, İç Hastalıkları ABD, Şanlıurfa, Türkiye
bSelçuk Üniversitesi Veteriner Fakültesi, İç Hastalıkları ABD, Konya, Türkiye
Turkiye Klinikleri J Vet Sci. 2022;13(1):20-9
doi: 10.5336/vetsci.2021-83003
Article Language: TR
Full Text
ÖZET
 Kedilerin intersitisyel sistitisi [feline interstitiel cystitis (FIC)], veteriner hekimlik pratiğinde sık karşılaşılan, patogenezisi tam olarak aydınlatılamamış ve hasta sahiplerinde hayal kırıklığı oluşturan bir klinik olgu olarak güncelliğini korumaktadır. FIC olgularında; pollaküri, periüri, strangüri ve/veya hematüri gibi alt üriner sistem hastalığı belirtileri ile birlikte davranış bozuklukları, deri, kalp, endokrin/nöroendokrin veya gastrointestinal sistem hastalığı belirtileri gözlenmektedir. Bu çok faktörlü doğası nedeniyle 'Pandora Sendromu' olarak tanımlanmaktadır. Multifaktöriyel doğası nedeniyle Pandora Sendromu, her yaş, cinsiyet ve coğrafi dağılıma bağlı olarak her ırktan kedide görülebilir. FIC olgularının idrar kesesi ile sınırlı olmayan bir klinik problem olduğu, sinir, endokrin ve bağışıklık sistemlerinin çoklu, karmaşık ve değişken anormalliklerini kapsadığı ifade edilmektedir. Klinik belirtileriyle bir alt üriner sistem hastalığı olarak görülen FIC olgularında, idrar kesesi duvarı permeabilitesinin artışı, vazodilatasyon, ödem, vasküler sızıntı, eritrosit diapedezi ve hücresel infiltrasyonla karakterize bir nörojenik yangı tablosu geliştiği ve stres durumlarında idrar kesesinin sensörik uyarımını artıran adrenokortikal cevabın azalması ve sempatik sinir sistemi uyarımının artışı gibi nöroendokrin aks değişimleri olduğu bildirilmektedir. Tedavi yönetiminde çevresel düzenleme uygulamalarının başarılı olması, FIC olgusunun sadece bir alt üriner sistem hastalığı olarak görülmemesi gerektiğini ve çok yönlü tanısal değerlendirmelere ihtiyaç olduğunu göstermektedir. Sunulan derlemede, FIC olgularının patofizyolojisi, klinik belirtileri, stres ve tedavi yönetimini içeren güncel yaklaşımlara yer verilmiştir.

Anahtar Kelimeler: Kedi; stres; intersitisyel sistitis; feline intersitisyel sistitis; multimodel çevresel modifikasyon
ABSTRACT
 Feline interstitial cystitis (FIC) is a clinical phenomenon that is common in veterinary practice which its pathogenesis has not been fully elucidated and causes disappointment with owners. In FIC cases; behavioral disorders, skin, heart, endocrine/neuroendocrine or gastrointestinal system disease symptoms are observed together with lower urinary tract disease symptoms such as pollakiuria, periuria, stranguri and/or hematuria. It is defined as "Pandora Syndrome" due to its multifactorial nature. Due to its multifactorial nature, Pandora Syndrome can be seen in cats of all breeds, depending on age, sex and geographical distribution. It is stated that FIC cases are a clinical problem that is not limited to the bladder, and they include multiple, complex and variable abnormalities of the nervous, endocrine and immune systems. It has been reported in FIC that as a lower urinary system disease, a neurogenic inflammation characterized by increased urinary bladder wall permeability, vasodilation, edema, vascular leakage, erythrocyte diapedesis and cellular infiltration develops and during stress, decreased adrenocortical response and sympathetic nerve increase the sensory stimulation of the urinary bladder and changes in the neuroendocrine axis, such as increased stimulation. The success of environmental enrichment in treatment shows that FIC should not be defined as only a lower urinary system disease and that multidimensional diagnostic evaluations are needed. In this review, current approaches including the pathophysiology, clinical symptoms, stress and treatment management of FIC cases are presented.

Keywords: Cat; stress; interstitial cystitis; feline interstitial cystitis; mutimodal environmental modification
REFERENCES:
  1. Westropp JL, Delgado M, Buffington CAT. Chronic lower urinary tract signs in cats: Current understanding of pathophysiology and management. Vet Clin North Am Small Anim Pract. 2019;49(2):187-209. [Crossref]  [PubMed] 
  2. May A. Chronic pain may change the structure of the brain. Pain. 2008;137(1):7-15. [Crossref]  [PubMed] 
  3. Mayer EA, Bushnell MC. Functional pain disorders: time for a paradigm shift. Functional pain syndromes: presentation and pathophysiology. Seattle: IASP Press; 2009. p.531-66. [Link] 
  4. Forrester SD, Towell TL. Feline idiopathic cystitis. Vet Clin North Am Small Anim Pract. 2015;45(4):783-806. [Crossref]  [PubMed] 
  5. Vieira ANLS, Ramos PRR, Melchert A, Okamoto PTCG. Feline Pandora's Syndrome: A bibliographic review. Vet. e Zootec. 2017;24(4):680-90. [Crossref] 
  6. Kruger JM, Osborne CA, Lulich JP. Changing paradigms of feline idiopathic cystitis. Vet Clin North Am Small Anim Pract. 2009;39(1):15-40. [Crossref]  [PubMed] 
  7. Westropp JL, Tony Buffington CA. Feline idiopathic cystitis: current understanding of pathophysiology and management. Vet Clin North Am Small Anim Pract. 2004;34(4):1043-55. [Crossref]  [PubMed] 
  8. Buffington CA. Idiopathic cystitis in domestic cats--beyond the lower urinary tract. J Vet Intern Med. 2011;25(4):784-96. [Crossref]  [PubMed]  [PMC] 
  9. Chew DJ, Buffington CA. Pandora Syndrome: It's More than Just the Bladder. American Association of Feline Practitioners Conference; 2013 Sep 26-29; Dallas, Texas. [Link] 
  10. Kruger JM, Conway TS, Kaneene JB, Perry RL, Hagenlocker E, Golombek A, et al. Randomized controlled trial of the efficacy of short-term amitriptyline administration for treatment of acute, nonobstructive, idiopathic lower urinary tract disease in cats. J Am Vet Med Assoc. 2003;222(6):749-58. [Crossref]  [PubMed] 
  11. Kaul E, Hartmann K, Reese S, Dorsch R. Recurrence rate and long-term course of cats with feline lower urinary tract disease. J Feline Med Surg. 2020;22(6):544-56. [Crossref]  [PubMed]  [PMC] 
  12. Kim Y, Kim H, Pfeiffer D, Brodbelt D. Epidemiological study of feline idiopathic cystitis in Seoul, South Korea. J Feline Med Surg. 2018;20(10):913-21. [Crossref]  [PubMed] 
  13. Lund HS, Sævik BK, Finstad ØW, Grøntvedt ET, Vatne T, Eggertsdóttir AV. Risk factors for idiopathic cystitis in Norwegian cats: a matched case-control study. J Feline Med Surg. 2016;18(6):483-91. [Crossref]  [PubMed] 
  14. Defauw PA, Van de Maele I, Duchateau L, Polis IE, Saunders JH, Daminet S. Risk factors and clinical presentation of cats with feline idiopathic cystitis. J Feline Med Surg. 2011;13(12):967-75. [Crossref]  [PubMed] 
  15. Tony Buffington CA, Westropp JL, Chew DJ. From FUS to Pandora syndrome: where are we, how did we get here, and where to now? J Feline Med Surg. 2014;16(5):385-94. [Crossref]  [PubMed] 
  16. Lekcharoensuk C, Osborne CA, Lulich JP. Epidemiologic study of risk factors for lower urinary tract diseases in cats. J Am Vet Med Assoc. 2001;218(9):1429-35. [Crossref]  [PubMed] 
  17. Gerber B, Eichenberger S, Reusch CE. Guarded long-term prognosis in male cats with urethral obstruction. J Feline Med Surg. 2008;10(1):16-23. Erratum in: J Feline Med Surg. 2009;11(4):337. [Crossref]  [PubMed] 
  18. Sævik BK, Trangerud C, Ottesen N, Sørum H, Eggertsdóttir AV. Causes of lower urinary tract disease in Norwegian cats. J Feline Med Surg. 2011;13(6):410-7. [Crossref]  [PubMed] 
  19. Buffington CA, Chew DJ. Management of non-obstructive idiopathic/interstitial cystitis in cats. In: Elliott J, Grauer GF, Westropp J, eds. BSAVA Manual of Canine and Feline Nephrology and Urology. 3rd ed. BSAVA Library: 2017. p. 317-327. [Crossref] 
  20. Osborne CA, Caywood DD, Johnston GR, Polzin DJ, Lulich JP, Kruger JM, et al. Feline perineal urethrostomy: a potential cause of feline lower urinary tract disease. Vet Clin North Am Small Anim Pract. 1996;26(3):535-49. [Crossref]  [PubMed] 
  21. Aizawa N. [Afferent nerve activity in relation to bladder sensation]. Nihon Yakurigaku Zasshi. 2019;154(5):255-258. Japanese. [Crossref]  [PubMed] 
  22. Gunn-Moore D. Feline lower urinary tract disease. J Feline Med Surg. 2003;5(2):133-8. [Crossref]  [PubMed] 
  23. Stella JL, Lord LK, Buffington CA. Sickness behaviors in response to unusual external events in healthy cats and cats with feline interstitial cystitis. J Am Vet Med Assoc. 2011; 238(1):67-73. [Crossref]  [PubMed]  [PMC] 
  24. Kruger JM, Osborne CA, Lulich JP. Management of nonobstructive idiopathic feline lower urinary tract disease. Vet Clin North Am Small Anim Pract. 1996;26(3):571-88. [Crossref]  [PubMed] 
  25. Rubio-Diaz DE, Pozza ME, Dimitrakov J, Gilleran JP, Giusti MM, Stella JL, et al. A candidate serum biomarker for bladder pain syndrome/interstitial cystitis. Analyst. 2009;134(6): 1133-7. [Crossref]  [PubMed]  [PMC] 
  26. Parys M, Yuzbasiyan-Gurkan V, Kruger JM. Serum Cytokine Profiling in Cats with Acute Idiopathic Cystitis. J Vet Intern Med. 2018; 32(1):274-9. [Crossref]  [PubMed]  [PMC] 
  27. Carney HC, Little S, Brownlee-Tomasso D, Harvey AM, Mattox E, Robertson S, et al; American Association of Feline Practitioners; International Society of Feline Medicine. AAFP and ISFM feline-friendly nursing care guidelines. J Feline Med Surg. 2012;14(5):337-49. [Crossref]  [PubMed] 
  28. Buffington CA, Westropp JL, Chew DJ, Bolus RR. Clinical evaluation of multimodal environmental modification (MEMO) in the management of cats with idiopathic cystitis. J Feline Med Surg. 2006;8(4):261-8. [Crossref]  [PubMed] 
  29. Stella J, Croney C, Buffington T. Effects of stressors on the behavior and physiology of domestic cats. Appl Anim Behav Sci. 2013; 143(2-4):157-63. [Crossref]  [PubMed]  [PMC] 
  30. Stella J, Croney C, Buffington T. Environmental factors that affect the behaviour and welfare of domestic cats (Felis silvestris catus) housed in cages. Appl Anim Behav Sci. 2014;160:94-105. [Crossref] 
  31. Morgan KN, Tromborg CT. Sources of stress in captivity. Appl Anim Behav Sci. 2007;102(3-4):262-302. [Crossref] 
  32. Han E, Nguyen L, Sirls L, Peters K. Current best practice management of interstitial cystitis/bladder pain syndrome. Ther Adv Urol. 2018;10(7):197-211. [Crossref]  [PubMed]  [PMC] 
  33. Hanno PM, Erickson D, Moldwin R, Faraday MM; American Urological Association. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amend ment. J Urol. 2015;193(5):1545-53. [PubMed] 
  34. Tirlapur SA, Burch JV, Carberry CL. On behalf of the Royal College of Obstetricians and Gynecologists. Management of bladder pain syndrome. BJOG. 2016;124(2):46-72. [Link] 
  35. Frankel RM. Pets, vets, and frets: what relationship-centered care research has to offer veterinary medicine. J Vet Med Educ. 2006; 33(1):20-7. [Crossref]  [PubMed] 
  36. Sinn L. Advances in behavioral psychopharmacology. Vet Clin North Am Small Anim Pract. 2018;48(3):457-71. [Crossref]  [PubMed] 
  37. Chew DJ, Buffington CA, Kendall MS, DiBartola SP, Woodworth BE. Amitriptyline treatment for severe recurrent idiopathic cystitis in cats. J Am Vet Med Assoc. 1998;213(9):1282-6. [PubMed] 
  38. Hart BL, Cliff KD, Tynes VV, Bergman L. Control of urine marking by use of long-term treatment with fluoxetine or clomipramine in cats. J Am Vet Med Assoc. 2005;226(3):378-82. [Crossref]  [PubMed] 
  39. Hanno PM, Wolf S. Guidelines Q&A: diagnosis and treatment of interstitial cystitis/bladder pain syndrome. In: Labato MA, Acierno MJ, eds. Health policy brief. Linthicum (MD): American Urological Association; 2013. p. 2162-70. [Link] 
  40. Chew DJ, Bartges JW, Adams LG, Kruger JM, Buffington CAT. Randomized, placebo-controlled clinical trial of pentosan polysulfate sodium for treatment of feline interstitial (idiopathic) cystitis. J Vet Intern Med. 2009;23:690. [Link] 
  41. Gunn-Moore DA, Shenoy CM. Oral glucosamine and the management of feline idiopathic cystitis. J Feline Med Surg. 2004; 6(4):219-25. [Crossref]  [PubMed] 
  42. Veir J, Webb C, Lappin M. Systemic effects of a commercial preparation of chondroitin sulfate, hyaluronic acid and N acetyl-D-glucosamine when administered parenterally to healthy cats. Intern J Appl Res Vet Med. 2013;11(2):91-5. [Link] 
  43. Bradley AM, Lappin MR. Intravesical glycosaminoglycans for obstructive feline idiopathic cystitis: a pilot study. J Feline Med Surg. 2014;16(6):504-6. [Crossref]  [PubMed] 
  44. Osborne CA, Caywood DD, Johnston GR, Polzin DJ, Lulich JP, Kruger JM. "Perineal urethrostomy versus dietary management in prevention of recurrent lower urinary tract disease". JSAP. 1991;32(6):296-305. [Crossref] 
  45. Beynen AC. Diet and feline idiopathic cystitis. Dier en Arts. 2016;1(2):18-21. [Link] 
  46. Kruger JM, Lulich JP, MacLeay J, Merrills J, Paetau-Robinson I, Brejda J, et al. Comparison of foods with differing nutritional profiles for long-term management of acute nonobstructive idiopathic cystitis in cats. J Am Vet Med Assoc. 2015;247(5):508-17. [Crossref]  [PubMed] 
  47. Pageat P, Gaultier E. Current research in canine and feline pheromones. Vet Clin North Am Small Anim Pract. 2003;33(2):187-211. Erratum in: Vet Clin North Am Small Anim Pract. 2003;33(4):10. [Crossref]  [PubMed] 
  48. Bryan J, Frank LA. Food allergy in the cat: a diagnosis by elimination. J Feline Med Surg. 2010;12(11):861-6. [Crossref]  [PubMed] 
  49. Mills DS, Redgate SE, Landsberg GM. A meta-analysis of studies of treatments for feline urine spraying. PLoS One. 2011;6(4): e18448. [Crossref]  [PubMed]  [PMC] 
  50. Chadwin RM, Bain MJ, Kass PH. Effect of a synthetic feline facial pheromone product on stress scores and incidence of upper respiratory tract infection in shelter cats. J Am Vet Med Assoc. 2017;251(4):413-20. [Crossref]  [PubMed] 

.: Up To Date

.: Process List

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com